Yue Ding, MD
Rheumatology · Ann Arbor, MINPI 1104213834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $121 and has fallen 65.0% since, to $42 in 2024. That places this record below the midpoint for rheumatology clinicians in MI, where the typical reported total is $1,854.
Across 13 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$50
- Pfizer$42
- Actelion Pharmaceuticals US, Inc.$40
- United Therapeutics Corporation$25
- Mallinckrodt Hospital Products Inc.$24
- E.r. Squibb & Sons, L.L.C.$23
- plus $93 from 5 others
What the payments were for
- Food & beverage$297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 2 | $50 |
| Pfizer | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| United Therapeutics Corporation | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| GSK | 1 | $22 |
| Octapharma USA, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| AbbVie | 1 | $19 |
| Gilead | 1 | $14 |
How this compares
$297 in reported general payments places this provider in the 30th percentile of 195 rheumatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 24 | $169,804 |
| Actemra ActpenTocilizumab | 20 | $97,259 |
| Humira PenAdalimumab | 11 | $73,359 |
| Leflunomide | 31 | $1,624 |
| MethotrexateMethotrexate Sodium | 70 | $1,136 |
| Prednisone | 77 | $678 |
| Hydroxychloroquine Sulfate | 19 | $625 |
| Allopurinol | 38 | $239 |
| Methylprednisolone | 16 | $103 |
| Meloxicam | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Ann Arbor
- Dinesh KhannaAnn Arbor$1.2M
- Elena SchiopuAnn Arbor$180K
- Daniel ClauwAnn Arbor$102K
- Katherine ChakrabartiAnn Arbor$82K
- Puja KhannaAnn Arbor$78K
- Joanne KahlenbergAnn Arbor$74K
- John VargaAnn Arbor$64K
- Samardeep GuptaAnn Arbor$58K
- Jason KnightAnn Arbor$38K
- Sheeja FrancisAnn Arbor$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.